The "Global Vaccine Delivery Devices Market Analysis & Forecast to 2024-2034" report has been added to ResearchAndMarkets.com ...

Aldevron, a leading global manufacturer of DNA, RNA, and proteins used in cell and gene therapies and vaccine development, ...

This partnership will allow Aldevron to expand its capabilities in mRNA LNP encapsulation by incorporating Acuitas’ proprietary LNP encapsulation platform, increasing Aldevron’s services and ...

This partnership will allow Aldevron to expand its capabilities in mRNA LNP encapsulation by incorporating Acuitas’ proprietary LNP encapsulation platform, increasing Aldevron’s services and ...

An experimental mRNA vaccine against avian influenza virus H5N1 is highly effective in preventing severe illness and death in ...

Story updated at 9:57 p.m. The homes of University of Michigan regents have become the latest front for protesters demanding ...

In a report released today, Roy Buchanan from JMP Securities reiterated a Buy rating on CureVac (CVAC – Research Report), with a price ...

Ontrak, Inc. (NASDAQ: OTRK) ("Ontrak" or the "Company"), a leading AI-powered and technology-enabled behavioral healthcare ...

As a few examples, he highlighted high-profile researchers such as biochemistry and molecular biology professor Pieter Cullis, co-founder of several companies including Acuitas Therapeutics ...